Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -14.14% is 47% above its 5-year average of -26.58%, near the high end of its 5-year range (-44.78%–-14.14%).
46.59% above its 12-month average of -26.48%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -5.31%.
RETURN ON ASSETS (ROA)
-14.14%
RETURN ON ASSETS (ROA) AVG TTM
-26.48%
RETURN ON ASSETS (ROA) AVG 3Y
-30.34%
RETURN ON ASSETS (ROA) AVG 5Y
-26.58%
RETURN ON ASSETS (ROA) AVG 10Y
-14.59%
RETURN ON ASSETS (ROA) AVG 15Y
-15.28%
RETURN ON ASSETS (ROA) AVG 20Y
-10.63%
CURRENT VS TTM AVG
+46.59%
CURRENT VS 3Y AVG
+53.39%
CURRENT VS 5Y AVG
+46.80%
CURRENT VS 10Y AVG
+3.07%
CURRENT VS 15Y AVG
+7.47%
CURRENT VS 20Y AVG
-33.07%
SECTOR MEDIAN · HEALTHCARE
-29.12%
median of 605 covered companies
CURRENT VS SECTOR MEDIAN
+51.44%
vs the sector median at left
Apyx Medical Corporation
Market Cap
$109.07M
Return on Assets (ROA)
-14.14%
TTM Avg
-26.48%
3Y Avg
-30.34%
5Y Avg
-26.58%
Market Cap
$109.42M
Return on Assets (ROA)
-85.80%
TTM Avg
-37.85%
3Y Avg
-56.27%
5Y Avg
-56.27%
Market Cap
$107.43M
Return on Assets (ROA)
-16.87%
TTM Avg
-6.13%
3Y Avg
-6.48%
5Y Avg
-5.59%
Market Cap
$111.14M
Return on Assets (ROA)
-4.60%
TTM Avg
-3.66%
3Y Avg
-5.21%
5Y Avg
-1.02%
Market Cap
$106.44M
Return on Assets (ROA)
-80.25%
TTM Avg
-36.24%
3Y Avg
-78.62%
5Y Avg
-77.58%
Market Cap
$106.56M
Return on Assets (ROA)
-70.09%
TTM Avg
-324.97%
3Y Avg
-229.15%
5Y Avg
-168.27%
Market Cap
$106.58M
Return on Assets (ROA)
-34.04%
TTM Avg
-20.59%
3Y Avg
-37.88%
5Y Avg
-37.10%
Market Cap
$111.93M
Return on Assets (ROA)
-31.75%
TTM Avg
-34.00%
3Y Avg
-32.33%
5Y Avg
-29.29%
Market Cap
$111.86M
Return on Assets (ROA)
-0.05%
TTM Avg
-38.03%
3Y Avg
-60.31%
5Y Avg
-59.32%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apyx Medical Corporation (APYX) | $109.07M | -14.14% | -26.48% | -30.34% | -26.58% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $109.42M | -85.80% | -37.85% | -56.27% | -56.27% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $107.43M | -16.87% | -6.13% | -6.48% | -5.59% |
| BGM Group Ltd. (BGM)vs › | $111.14M | -4.60% | -3.66% | -5.21% | -1.02% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.44M | -80.25% | -36.24% | -78.62% | -77.58% |
| Immunic, Inc. (IMUX)vs › | $106.56M | -70.09% | -324.97% | -229.15% | -168.27% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $106.58M | -34.04% | -20.59% | -37.88% | -37.10% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $111.93M | -31.75% | -34.00% | -32.33% | -29.29% |
| Coya Therapeutics, Inc. (COYA)vs › | $111.86M | -0.05% | -38.03% | -60.31% | -59.32% |
| Definitive Healthcare Corp. (DH)vs › | $104.99M | -33.85% | -28.41% | -17.06% | -12.28% |
ROA
-14.1%
ROE
-81.0%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -16.77% |
| 2024-12-31 | -36.18% |
| 2023-12-31 | -23.62% |
| 2022-12-31 | -44.78% |
| 2021-12-31 | -22.08% |
| 2020-12-31 | -16.05% |
| 2019-12-31 | -23.27% |
| 2018-12-31 | 66.95% |
| 2017-12-31 | -16.34% |
| 2016-12-31 | -11.25% |
| 2015-12-31 | -17.08% |
| 2014-12-31 | -69.59% |
| 2013-12-31 | -13.08% |
| 2012-12-31 | 2.19% |
| 2011-12-31 | 0.39% |
| 2010-12-31 | -5.52% |
| 2009-12-31 | 2.16% |
| 2008-12-31 | 7.11% |
| 2007-12-31 | 12.75% |
| 2006-12-31 | 16.08% |
| 2005-12-31 | 3.45% |
| 2004-12-31 | 13.72% |
| 2003-12-31 | 7.38% |
| 2002-12-31 | -6.06% |
| 2001-12-31 | 9.14% |
| 2000-12-31 | 6.33% |
| 1999-12-31 | -29.74% |
| 1998-12-31 | -9.36% |
| 1997-12-31 | 2.58% |
| 1996-12-31 | 10.45% |
